Browse All

Current Filters

CLEAR FILTER x

TITLE

Title
    Author Last Name
      Session Name
        Topic
          Program Number
            Author Institution

              Real-World Long-Term Effectiveness of Fremanezumab in Patients With Migraine Who Switched From Another mAb Targeting the CGRP Pathway – Subgroup Analysis of the FINESSE Full Analysis

              Author:Straube, Andreas   Broessner, Gregor   Gaul, Charly   Hamann, Xenia   Kraya, Torsten   Neeb, Lars   

              Session Name:P10: Headache: Advances in CGRP Inhibitors and Migraine 3  

              Topic:Headache  

              Program Number:P10.009  

              Author Institution:University Clinic Munich, LMU, Neurology, Munich, Germany, Munich, Germany  Innsbruck Medical University, Neurology, Innsbruck, Austria, Innsbruck, Austria  Headache Center Frankfurt, Frankfurt am Main, Germany, Frankfurt Am Main, Germany  Teva GmbH, Ulm, Germany, Ulm, Germany